Try These New Flavors of Actively-Managed ESG ETFs
Justin Kuepper
|
We'll examine two recently launched actively-managed ESG ETFs offering a unique spin on...
The firm has raised its 2015 EPS estimates from $2.07 to $2.08. FY2016 EPS estimates were increased from $2.21 to $2.30.
The analyst commented: “We expect PFE shares to significantly appreciate over the next 1-2 years based on a better than expected launch of Ibrance, greater appreciation of the durable growth on offer in GEP, further accretive and potentially tax-driven M&A, and the separation of GEP by 2017 at a minimum from the rest of the business.”
The stock has grown at a steady rate over the last few years and has a dividend yield of about 3.2%. Pfizer stock is perhaps most ideal for income-focused investors that are planning on holding the stock over the long-haul.
Symbol | Mutual Fund | Stake |
---|---|---|
VTSMX | Vanguard Total Stock Mkt Idx | 1.79% |
VFINX | Vanguard 500 Index | 1.15% |
FKINX | Franklin Income | 0.72% |
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Receive email updates about best performers, news, CE accredited webcasts and more.
Justin Kuepper
|
We'll examine two recently launched actively-managed ESG ETFs offering a unique spin on...
News
Justin Kuepper
|
The S&P 500 index posted a respectable year-to-date increase of approximately 5.3%, but...
Aaron Levitt
|
For fixed income investors, using covered calls on their stock sleeve has the...
Mutual Fund Education
Justin Kuepper
|
Let's take a closer look at how ESG investments have outperformed during the...
Mutual Fund Education
Daniel Cross
|
While CITs and mutual funds share many similarities, there are some key differences...
Mutual Fund Education
Sam Bourgi
|
The phrase ‘bear market’ has been thrown around a lot lately, but it...
The firm has raised its 2015 EPS estimates from $2.07 to $2.08. FY2016 EPS estimates were increased from $2.21 to $2.30.
The analyst commented: “We expect PFE shares to significantly appreciate over the next 1-2 years based on a better than expected launch of Ibrance, greater appreciation of the durable growth on offer in GEP, further accretive and potentially tax-driven M&A, and the separation of GEP by 2017 at a minimum from the rest of the business.”
The stock has grown at a steady rate over the last few years and has a dividend yield of about 3.2%. Pfizer stock is perhaps most ideal for income-focused investors that are planning on holding the stock over the long-haul.
Symbol | Mutual Fund | Stake |
---|---|---|
VTSMX | Vanguard Total Stock Mkt Idx | 1.79% |
VFINX | Vanguard 500 Index | 1.15% |
FKINX | Franklin Income | 0.72% |
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Receive email updates about best performers, news, CE accredited webcasts and more.
Justin Kuepper
|
We'll examine two recently launched actively-managed ESG ETFs offering a unique spin on...
News
Justin Kuepper
|
The S&P 500 index posted a respectable year-to-date increase of approximately 5.3%, but...
Aaron Levitt
|
For fixed income investors, using covered calls on their stock sleeve has the...
Mutual Fund Education
Justin Kuepper
|
Let's take a closer look at how ESG investments have outperformed during the...
Mutual Fund Education
Daniel Cross
|
While CITs and mutual funds share many similarities, there are some key differences...
Mutual Fund Education
Sam Bourgi
|
The phrase ‘bear market’ has been thrown around a lot lately, but it...